- Addex Announces Upcoming Conferences it will participate for H1 2023
- Addex Regains Nasdaq Listing Compliance
- Addex Strategic Partner Completes Enrollment in ADX71149 Epilepsy Phase 2 Study Part 1
- Addex Provides Corporate Update and Financial Guidance
- Addex and Indivior Extend Research Term of Substance Use Disorder GABAB Positive Allosteric Modulator Discovery Collaboration
- Addex Reports Q3 2022 Financial Results and Provides Corporate Update
- Addex Therapeutics to Report Third Quarter 2022 Financial Results and Host Conference Call on November 11, 2022
- Addex Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
- Addex Increases Issued Share Capital to Create Treasury Shares
- Addex to Present at the Sachs Associates 22nd Annual Biotech in Europe Forum & Baader Investment Conference
Addex Therapeutics Ltd (APE0:DEU) closed at 0.99, 94.12% above the 52 week low of 0.51 set on Dec 29, 2022.
0.51Dec 29 20225.10Apr 27 2022
Short selling activityProvided by S&P Global Market Intelligence
|Market cap||22.41m USD|
Data delayed at least 15 minutes, as of Mar 27 2023 19:30 BST.